Sarepta Therapeutics note 1.500% 11/1 shares owned by Royal Bank of Canada
Quarter-by-quarter ownership of Sarepta Therapeutics note 1.500% 11/1 shares owned by Royal Bank of Canada
from 13F filings
Historical chart of Royal Bank of Canada investment in Sarepta Therapeutics note 1.500% 11/1
Tip: Access up to 7 years of quarterly data
All positions including Sarepta Therapeutics note 1.500% 11/1 held by Royal Bank of Canada consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Sarepta Therapeutics note 1.500% 11/1 by Royal Bank of Canada
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2023-12-31 | $3.0k | 2.0k | 1.50 |
2023-09-30 | $4.0k | 2.0k | 2.00 |
2023-06-30 | $3.0k | 2.0k | 1.50 |
2022-12-31 | $4.0k | 2.0k | 2.00 |
2022-09-30 | $4.5k | 3.0k | 1.50 |
2021-06-30 | $3.0k | 2.0k | 1.50 |
2021-03-31 | $3.0k | 2.0k | 1.50 |
2020-12-31 | $5.0k | 2.0k | 2.50 |
2020-09-30 | $4.0k | 2.0k | 2.00 |
2020-06-30 | $6.0k | 3.0k | 2.00 |
2020-03-31 | $4.5k | 3.0k | 1.50 |
2019-12-31 | $6.0k | 3.0k | 2.00 |
2019-09-30 | $3.0k | 3.0k | 1.00 |
2019-03-31 | $12M | 6.7M | 1.80 |
Top funds holding Sarepta Therapeutics note 1.500% 11/1
View all funds holding Sarepta Therapeutics note 1.500% 11/1